Pharmacotherapy of borderline personality disorder

Robert M.A. Hirschfeld

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.

Original languageEnglish (US)
Pages (from-to)48-52
Number of pages5
JournalJournal of Clinical Psychiatry
Issue numberSUPPL. 14
StatePublished - 1997
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Pharmacotherapy of borderline personality disorder'. Together they form a unique fingerprint.

Cite this